A detailed history of Cable Hill Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cable Hill Partners, LLC holds 8,428 shares of NVO stock, worth $736,354. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,428
Previous 8,394 0.41%
Holding current value
$736,354
Previous $1.2 Million 16.28%
% of portfolio
0.1%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$119.07 - $145.42 $4,048 - $4,944
34 Added 0.41%
8,428 $1 Million
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $1.03 Million - $1.23 Million
8,394 New
8,394 $1.2 Million
Q3 2023

Oct 27, 2023

BUY
$90.94 - $199.54 $418,051 - $917,285
4,597 Added 118.08%
8,490 $772,000
Q2 2023

Jul 19, 2023

SELL
$155.98 - $172.65 $63,639 - $70,441
-408 Reduced 9.49%
3,893 $630,000
Q1 2023

May 04, 2023

SELL
$132.34 - $159.14 $26,070 - $31,350
-197 Reduced 4.38%
4,301 $684,000
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $114,138 - $150,622
1,113 Added 32.88%
4,498 $608,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $322,522 - $395,808
3,385 New
3,385 $337,000
Q2 2019

Aug 06, 2019

SELL
$46.79 - $52.47 $75,799 - $85,001
-1,620 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $1,251 - $1,421
-27 Reduced 1.64%
1,620 $85,000
Q2 2018

Aug 03, 2018

SELL
$44.29 - $50.42 $4,517 - $5,142
-102 Reduced 5.83%
1,647 $76,000
Q1 2018

Apr 20, 2018

SELL
$48.49 - $58.14 $1,212 - $1,453
-25 Reduced 1.41%
1,749 $85,000
Q4 2017

Feb 22, 2018

BUY
$47.53 - $53.73 $3,944 - $4,459
83 Added 4.91%
1,774 $97,000
Q3 2017

Oct 27, 2017

BUY
$41.15 - $49.22 $69,584 - $83,231
1,691
1,691 $81,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.